A record the tape refused
Set the beat aside for a moment, because it is not in dispute. Revenue came in $2.558B above the top of the company's own $18.2B to $19.0B outlook. Non-GAAP EPS of $5.68 was 22.15% over consensus, the third straight quarter this fiscal year of beating it ($4.73 against $3.20 in Q1, $4.85 against $4.10 in Q2). The chief executive, Patrick Zammit, opened with "another record quarter, with Distribution and Hyve both performing above our expectations and growing above market." All of that checks out against the filing.
The stock still fell 9.88%, from $287.89 to about $259.44 (unverified — last regular-session trade, market data rather than a filing figure). I don't read that as the market disbelieving the demand. It read the other two statements in the release, the cash flow statement and the balance sheet, and saw that "growing above market" had become a question of who carries the inventory. For a distributor that has always been the real question. It is just usually too quiet to notice.
The income statement is the thin part
Gross margin fell 61 basis points to 6.61%, and it has fallen every quarter this year: 7.30%, 6.84%, 6.61%. What rescued operating income was SG&A, which rose only $36M to $783M, so the 2.98% operating margin widened even as gross margin narrowed. That operating leverage is genuine. But it sits on a business where 93.4% of every revenue dollar is cost of revenue before overhead touches it, which leaves very little room for error.
The mix explains the slide. By the presentation's numbers (unverified against the filing), Hyve billed about $7.0B, up 117%, and is now 22% of billings. On the same unverified basis, its operating income rose only 56%, to $253M, so its margin on billings fell to 3.61% from 5.04%. The chief financial officer called the new programs "neutral to accretive" (unverified pending the official transcript). What that phrase leaves out is that the programs are accretive in dollars and dilutive in rate, and the rate is what a distributor's multiple is built on. Distribution carried the profit, again per the presentation (unverified): $483M of operating income, up 55%, on billings up 27%, with Europe's operating income up 116%. The part of the business that earns the best returns grew slowest. The part that grew fastest is where the balance sheet went.
The rest of this dive is for paid subscribers.
The headline numbers are above. The 9 sections below carry the mechanism, the peer read, the valuation work, and the dated tests that decide it.
- Where the $416M went
- Two flat years, then a new floor
- The composite, and what it averages away
- The rebate that indexes to your own stock
- The guide says the same thing twice
- The strongest case against me
- What decides it
- The trade (analysis, not advice)
- Bottom line
Not ready to pay? Get the free Monday issue and one full dive a week by email.
Already a subscriber? Sign in.